Neurofilament Light Chain: A High-Performance Biomarker for Differentiating bvFTD from Primary Psychiatric Disorders
Highlights
- NfL levels in both CSF and blood are significantly elevated in patients with behavioral variant frontotemporal dementia (bvFTD) compared to those with primary psychiatric disorders.
- Blood-based NfL assays demonstrated high diagnostic performance, with AUCs reaching up to 0.98, suggesting a minimally invasive alternative to lumbar punctures.
- The biomarker provides critical objective data to resolve diagnostic uncertainty in middle-aged patients presenting with complex behavioral and personality changes.
The Diagnostic Dilemma in Neuropsychiatry
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.